Effects of Haloperidol and Atypical Neuroleptics on Psychomotor Performance and Driving Ability in Schizophrenic Patients

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Neuropsychobiology

• Publication date

  2003-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1159/000071217PMID 12824745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving.

  2002cited by this paper
• Dementia praecox and paraphrenia

  2002cited by this paper
• Gefährdung der Verkehrssicherheit durch Alkohol, Drogen und Benzodiazepine - ein Überblick

  2002cited by this paper
• Psychomotor Performance Under Neuroleptic Treatment in Schizophrenia

  2001cited by this paper
• Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.

  2001cited by this paper
• Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.

  2000cited by this paper
• Begutachtungs-Leitlinien zur Kraftfahrereignung des Gemeinsamen Beirats fuer Verkehrsmedizin beim Bundesministerium fuer Verkehr, Bau- und Wohnungswesen und beim Bundesministerium fuer Gesundheit

  2000cited by this paper
• The Influence of Clozapine and Typical Neuroleptics on Information Processing ofthe Central Nervous System under Clinical Conditions in Schizophrenic Disorders: Implications for Fitness to Drive

  1999cited by this paper
• The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.

  1999cited by this paper
• Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic.

  1999cited by this paper
• Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients.

  1998cited by this paper
• Zum Problem der Fahrtauglichkeit schizophrener Patienten unter Neuroleptikatherapie

  1998cited by this paper
• Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

  1997cited by this paper
• Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs.

  1996cited by this paper
• What are the functional consequences of neurocognitive deficits in schizophrenia?

  1996cited by this paper
• The Effect of Risperidone on Cognition in Patients with Schizophrenia

  1996cited by this paper
• The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

  1994cited by this paper
• Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

  1993cited by this paper
• VALIDIERUNG VERKEHRSPSYCHOLOGISCHER TESTVERFAHREN

  1990cited by this paper
• Neuropsychological assessment of monozygotic twins discordant for schizophrenia.

  1990cited by this paper
• Sensorimotor and Cognitive Performance of Schizophrenic Inpatients Treated with Haloperidol, Flupenthixol, or Clozapine

  1988cited by this paper

• Utilizing Technology to Enhance the Ecological Validity of Cognitive and Functional Assessments in Schizophrenia: An Overview of the State-of-the-Art

  2024cites this paper
• Comparative assessment of effect on psychomotor performance efficacy and adherence of levosulpiride and olanzapine in patients with schizophrenia: A parallel, open-label, prospective observational study

  2023cites this paper
• Driving fitness in clinically stable outpatients with chronic schizophrenia.

  2022cites this paper
• Driving Performance Under Treatment of Most Frequently Prescribed Drugs for Mental Disorders: A Systematic Review of Patient Studies

  2021cites this paper
• Effects of Psychopharmacological Medicines upon Driving Ability

  2021cites this paper
• Saskatchewan Psychiatric Occupational Therapy Driving Screen

  2020cites this paper
• Simulated car driving and its association with cognitive abilities in patients with schizophrenia.

  2019cites this paper
• Evaluation method regarding the effect of psychotropic drugs on driving performance: A literature review

  2018cites this paper
• Editorial to Driving Ability and Psychotropic Drugs

  2017cites this paper
• Driving skills in unmedicated first- and recurrent-episode schizophrenic patients

  2015cites this paper
• 違法薬物・医薬品の使用と自動車運転 —疫学的・実験的研究，及び対策の概観—

  2014cites this paper
• Fahrtauglichkeit bei affektiven Störungen und unter Psychopharmaka

  2014cites this paper
• Fahrtauglichkeit bei Abhängigkeitserkrankungen und Schizophrenie

  2014cites this paper
• Vpliv psihotropnih zdravil na vozniške sposobnosti

  2013cites this paper
• Car driving in schizophrenia: can visual memory and organization make a difference?

  2013cites this paper
• 11 – Psychopharmaka und Fahrtauglichkeit/Alltagssicherheit

  2012cites this paper
• Psychomotor Performance Relevant to Driving Ability in Patients with Schizophrenia Treated with Haloperidol and Aripiprazole

  2012cites this paper
• Driving Ability under Sertindole

  2011cites this paper
• Assessment of older drivers in New Zealand: The current system, research and recommendations

  2011cites this paper
• Psychopharmaka und Fahrtüchtigkeit

  2010cites this paper
• Influence of chronic illness on crash involvement of motor vehicle drivers: 2nd edition

  2010cites this paper
• Psychoactive medications that act on the central nervous system and crash involvement for older drivers: A population-based study

  2010influential citation
• Fahrtauglichkeit unter Antipsychotika

  2010cites this paper
• Mental health services utilization and driving violations

  2010cites this paper
• Driving simulator performance and psychomotor functions of schizophrenic patients treated with antipsychotics

  2009cites this paper
• Age-related slowing of movement as basal ganglia dysfunction

  2008cites this paper
• Fitness-to-Drive in Persons with Psychiatric Disorders and Those Using Psychotropic Medications

  2008cites this paper
• Psychopharmaka und Verkehrssicherheit

  2008cites this paper
• Fahrtauglichkeit unter Psychopharmaka

  2007cites this paper
• Angiotensin-II-Rezeptorantagonisten und endotheliale Progenitorzellen: ein neuer therapeutischer Ansatz?

  2007cites this paper
• Effects of Psychotropics on Driving Performance

  2006cites this paper
• Drugs and driving

  2006cites this paper
• Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.

  2005cites this paper
• Driving ability in schizophrenic patients: effects of neuroleptics

  2005cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2004cites this paper
• Fahrtüchtigkeit und psychische Erkrankung

  2004cites this paper
• Current awareness in human psychopharmacology

  2003cites this paper